Plasmid interference for curing antibiotic resistance plasmids in vivo

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Kamruzzaman, Muhammad ^a   Shoma, Shereen ^a   Thomas, Christopher M ^b   Partridge, Sally R ^a,c   Iredell, Jonathan R ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; FOSFOMYCIN; GENTAMICIN; RIFAMPICIN; SODIUM AZIDE; TETRACYCLINE; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; MOUSE; NONHUMAN; PLASMID; SEPSIS; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; ESCHERICHIA COLI; GENETICS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; REPLICON;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; FEMALE; KLEBSIELLA PNEUMONIAE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION; REPLICON;

EID: 85014287757     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0172913     Document Type: Article

References (61)

1. Peleg AY, Franklin C, Bell JM, Spelman DW. Dissemination of the metallo-ß-lactamase gene blaIMP-4 among Gram-negative pathogens in a clinical setting in Australia. Clin Infect Dis. 2005; 41(11): 1549-1556. doi: 10.1086/497831 PMID: 16267725
2. Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, et al. IMP-4, a novel metallo-ß- lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother. 2001; 45(3): 710-714. doi: 10.1128/AAC.45.3.710-714.2001 PMID: 11181348
3. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science. 1994; 264 (5157): 375-382 PMID: 8153624
4. Espedido B, Iredell J, Thomas L, Zelynski A. Wide dissemination of a carbapenemase plasmid among Gram-negative bacteria: Implications of the variable phenotype. J Clin Microbiol. 2005; 43(9): 4918-4919. doi: 10.1128/JCM.43.9.4918-4919.2005 PMID: 16145178
5. van Hal SJ, Wiklendt A, Espedido B, Ginn A, Iredell JR. Immediate appearance of plasmid-mediated resistance to multiple antibiotics upon antibiotic selection: An argument for systematic resistance epidemiology. J Clin Microbiol. 2009; 47(7): 2325-2327. doi: 10.1128/JCM.02141-08 PMID: 19420178
6. Rogers BA, Kennedy KJ, Sidjabat HE, Jones M, Collignon P, Paterson DL. Prolonged carriage of resistant E. Coli by returned travellers: Clonality, risk factors and bacterial characteristics. Eur J Clin Microbiol Infect Dis. 2012; 31(9): 2413-2420. doi: 10.1007/s10096-012-1584-z PMID: 22391758
7. Daneman N, Sarwar S, Fowler RA, Cuthbertson BH, Su DCSG. Effect of selective decontamination on antimicrobial resistance in intensive care units: A systematic review and meta-analysis. Lancet Infect Dis. 2013; 13(4): 328-341. doi: 10.1016/S1473-3099(12)70322-5 PMID: 23352693
8. de Smet AM, Kluytmans JA, Blok HE, Mascini EM, Benus RF, Bernards AT, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: An open-label, clustered group-randomised, crossover study. Lancet Infect Dis. 2011; 11(5): 372-380. doi: 10.1016/S1473-3099(11)70035-4 PMID: 21420908
9. Cuthbertson BH, Campbell MK, MacLennan G, Duncan EM, Marshall AP, Wells EC, et al. Clinical stakeholders' opinions on the use of selective decontamination of the digestive tract in critically ill patients in intensive care units: An international Delphi study. Crit Care. 2013; 17(6): R266. doi: 10. 1186/cc13096 PMID: 24207137
10. Duncan EM, Cuthbertson BH, Prior ME, Marshall AP, Wells EC, Todd LE, et al. The views of health care professionals about selective decontamination of the digestive tract: An international, theoretically informed interview study. J Crit Care. 2014; 29(4): 634-640. doi: 10.1016/j.jcrc.2014.03.013 PMID: 24747038
11. Novick RP. Plasmid incompatibility. Microbiol Rev. 1987; 51(4): 381-395 PMID: 3325793
12. Austin S, Nordstrom K. Partition-mediated incompatibility of bacterial plasmids. Cell. 1990; 60(3): 351-354. PMID: 2406018
13. Garcillan-Barcia MP, de la Cruz F. Why is entry exclusion an essential feature of conjugative plasmids? Plasmid. 2008; 60(1): 1-18. doi: 10.1016/j.plasmid.2008.03.002 PMID: 18440635
14. Sakuma T, Tazumi S, Furuya N, Komano T. ExcA proteins of IncI1 plasmid R64 and IncI? plasmid R621a recognize different segments of their cognate TraY proteins in entry exclusion. Plasmid. 2013; 69(2): 138-145. doi: 10.1016/j.plasmid.2012.11.004 PMID: 23201046
15. Thisted T, Sorensen NS, Wagner EG, Gerdes K. Mechanism of post-segregational killing: Sok antisense RNA interacts with Hok mRNA via its 5'-end single-stranded leader and competes with the 3'-end of Hok mRNA for binding to the mok translational initiation region. EMBO J. 1994; 13(8): 1960-1968 PMID: 8168493
16. Sengupta M, Austin S. Prevalence and significance of plasmid maintenance functions in the virulence plasmids of pathogenic bacteria. Infect Immun. 2011; 79(7): 2502-2509. doi: 10.1128/IAI.00127-11 PMID: 21555398
17. Yamaguchi Y, Park JH, Inouye M. Toxin-antitoxin systems in bacteria and archaea. Annu Rev Genet. 2011; 45: 61-79. doi: 10.1146/annurev-genet-110410-132412 PMID: 22060041
18. Unterholzner SJ, Poppenberger B, Rozhon W. Toxin-antitoxin systems: Biology, identification, and application. Mob Genet Elements. 2013; 3(5): E26219. doi: 10.4161/mge.26219 PMID: 24251069
19. Hayes F. Toxins-antitoxins: Plasmid maintenance, programmed cell death, and cell cycle arrest. Science. 2003; 301(5639): 1496-1499. doi: 10.1126/science.1088157 PMID: 12970556
20. Carattoli A. Plasmids in Gram negatives: Molecular typing of resistance plasmids. Int J Med Microbiol. 2011; 301(8): 654-658. doi: 10.1016/j.ijmm.2011.09.003 PMID: 21992746
21. Mnif B, Harhour H, Jdidi J, Mahjoubi F, Genel N, Arlet G, et al. Molecular epidemiology of extendedspectrum ß-lactamase-producing Escherichia coli in Tunisia and characterization of their virulence factors and plasmid addiction systems. BMC Microbiol. 2013; 13: 147. doi: 10.1186/1471-2180-13-147 PMID: 23800277
22. Tagg KA, Iredell JR, Partridge SR. Complete sequencing of IncI1 sequence type 2 plasmid pJIE512b indicates mobilization of blaCMY-2 from an IncA/C plasmid. Antimicrob Agents Chemother. 2014; 58 (8): 4949-4952. doi: 10.1128/AAC.02773-14 PMID: 24890591
23. Bravo A, Ortega S, de Torrontegui G, Diaz R. Killing of Escherichia coli cells modulated by components of the stability system ParD of plasmid R1. Mol Gen Genet. 1988; 215(1): 146-151 PMID: 3071737
24. Goeders N, Van Melderen L. Toxin-antitoxin systems as multilevel interaction systems. Toxins (Basel). 2014; 6(1): 304-324.
25. Rocker A, Meinhart A. Type II toxin: Antitoxin systems. More than small selfish entities? Curr Genet. 2016; 62(2): 287-290. doi: 10.1007/s00294-015-0541-7 PMID: 26597447
26. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009; 53(6): 2227-2238. doi: 10.1128/AAC.01707-08 PMID: 19307361
27. Baquero F, Coque TM, de la Cruz F. Ecology and evolution as targets: The need for novel eco-evo drugs and strategies to fight antibiotic resistance. Antimicrob Agents Chemother. 2011; 55(8): 3649-3660. doi: 10.1128/AAC.00013-11 PMID: 21576439
28. Hale L, Lazos O, Haines A, Thomas C. An efficient stress-free strategy to displace stable bacterial plasmids. Biotechniques. 2010; 48(3): 223-228. doi: 10.2144/000113366 PMID: 20359304
29. Wang D, Gao Z, Wang H, Feng E, Zhu L, Liu X, et al. Curing both virulent mega-plasmids from Bacillus anthracis wild-type strain A16 simultaneously using plasmid incompatibility. J Microbiol Biotechnol. 2015; 25(10): 1614-1620. doi: 10.4014/jmb.1503.03083 PMID: 26059513
30. Ni B, Du Z, Guo Z, Zhang Y, Yang R. Curing of four different plasmids in Yersinia pestis using plasmid incompatibility. Lett Appl Microbiol. 2008; 47(4): 235-240 PMID: 19241516
31. Amabile-Cuevas CF, Heinemann JA. Shooting the messenger of antibiotic resistance: Plasmid elimination as a potential counter-evolutionary tactic. Drug discovery today. 2004; 9(11): 465-467. doi: 10. 1016/S1359-6446(03)02989-1 PMID: 15149615
32. Denap JC, Thomas JR, Musk DJ, Hergenrother PJ. Combating drug-resistant bacteria: Small molecule mimics of plasmid incompatibility as antiplasmid compounds. J Am Chem Soc. 2004; 126(47): 15402-15404. doi: 10.1021/ja044207u PMID: 15563166
33. Thomas JR, DeNap JC, Wong ML, Hergenrother PJ. The relationship between aminoglycosides' RNA binding proclivity and their antiplasmid effect on an IncB plasmid. Biochemistry. 2005; 44(18): 6800-6808. doi: 10.1021/bi0473298 PMID: 15865425
34. Schaufler K, Wieler LH, Semmler T, Ewers C, Guenther S. ESBL-plasmids carrying toxin-antitoxin systems can be "cured" of wild-type Escherichia coli using a heat technique. Gut pathogens. 2013; 5 (1): 34. doi: 10.1186/1757-4749-5-34 PMID: 24245987
35. Getino M, Sanabria-Rios DJ, Fernandez-Lopez R, Campos-Gomez J, Sanchez-Lopez JM, Fernandez A, et al. Synthetic fatty acids prevent plasmid-mediated horizontal gene transfer. mBio. 2015; 6(5): E01032-01015. doi: 10.1128/mBio.01032-15 PMID: 26330514
36. Getino M, Fernandez-Lopez R, Palencia-Gandara C, Campos-Gomez J, Sanchez-Lopez JM, Martinez M, et al. Tanzawaic acids, a chemically novel set of bacterial conjugation inhibitors. PLoS One. 2016; 11(1): E0148098. doi: 10.1371/journal.pone.0148098 PMID: 26812051
37. Zong Z, Partridge SR, Thomas L, Iredell JR. Dominance of blaCTX-M within an Australian extendedspectrum ß-lactamase gene pool. Antimicrob Agents Chemother. 2008; 52(11): 4198-4202. doi: 10. 1128/AAC.00107-08 PMID: 18725449
38. Guzman LM, Belin D, Carson MJ, Beckwith J. Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter. J Bacteriol. 1995; 177(14): 4121-4130 PMID: 7608087
39. Espedido BA, Partridge SR, Iredell JR. blaIMP-4 in different genetic contexts in Enterobacteriaceae isolates from Australia. Antimicrob Agents Chemother. 2008; 52(8): 2984-2987. doi: 10.1128/AAC.01634- 07 PMID: 18490506
40. Partridge SR, Ginn AN, Paulsen IT, Iredell JR. pEl1573 carrying blaIMP-4, from Sydney, Australia, is closely related to other IncL/M plasmids. Antimicrob Agents Chemother. 2012; 56(11): 6029-6032. doi: 10.1128/AAC.01189-12 PMID: 22926566
41. Jacoby GA, Han P. Detection of extended-spectrum ß-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol. 1996; 34(4): 908-911 PMID: 8815106
42. Hou J, Huang X, Deng Y, He L, Yang T, Zeng Z, et al. Dissemination of the fosfomycin resistance gene fosA3 with CTX-M ß-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob Agents Chemother. 2012; 56(4): 2135-2138. doi: 10.1128/AAC. 05104-11 PMID: 22232290
43. Gibson DG, Young L, Chuang RY, Venter JC, Hutchison CA 3rd, Smith HO. Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat Methods. 2009; 6(5): 343-345. doi: 10.1038/nmeth.1318 PMID: 19363495
44. Murphy KC, Campellone KG. Lambda Red-mediated recombinogenic engineering of enterohemorrhagic and enteropathogenic E. Coli. BMC Mol Biol. 2003; 4: 11. doi: 10.1186/1471-2199-4-11 PMID: 14672541
45. Zhang L. Voluntary oral administration of drugs in mice. Protocol Exchange. 2011:
46. Sevin EW, Barloy-Hubler F. RASTA-Bacteria: A web-based tool for identifying toxin-antitoxin loci in prokaryotes. Genome biology. 2007; 8(8): R155. doi: 10.1186/gb-2007-8-8-r155 PMID: 17678530
47. Shao Y, Harrison EM, Bi D, Tai C, He X, Ou HY, et al. TADB: A web-based resource for Type 2 toxinantitoxin loci in bacteria and archaea. Nucleic acids research. 2011; 39(Database issue): D606-611. doi: 10.1093/nar/gkq908 PMID: 20929871
48. Doumith M, Dhanji H, Ellington MJ, Hawkey P, Woodford N. Characterization of plasmids encoding extended-spectrum ß-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J Antimicrob Chemother. 2012; 67(4): 878-885. doi: 10.1093/jac/dkr553 PMID: 22210753
49. Mnif B, Vimont S, Boyd A, Bourit E, Picard B, Branger C, et al. Molecular characterization of addiction systems of plasmids encoding extended-spectrum ß-lactamases in Escherichia coli. J Antimicrob Chemother. 2010; 65(8): 1599-1603. doi: 10.1093/jac/dkq181 PMID: 20507859
50. Perez-Chaparro PJ, Cerdeira LT, Queiroz MG, de Lima CP, Levy CE, Pavez M, et al. Complete nucleotide sequences of two blaKPC-2-bearing IncN plasmids isolated from sequence type 442 Klebsiella pneumoniae clinical strains four years apart. Antimicrob Agents Chemother. 2014; 58(5): 2958-2960. doi: 10.1128/AAC.02341-13 PMID: 24566176
51. Chen L, Hu H, Chavda KD, Zhao S, Liu R, Liang H, et al. Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China. Antimicrob Agents Chemother. 2014; 58(4): 2422-2425. doi: 10.1128/AAC.02587-13 PMID: 24395232
52. Kassis-Chikhani N, Frangeul L, Drieux L, Sengelin C, Jarlier V, Brisse S, et al. Complete nucleotide sequence of the first KPC-2- And SHV-12-encoding IncX plasmid, pKpS90, from Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013; 57(1): 618-620. doi: 10.1128/AAC.01712-12 PMID: 23089759
53. Chen L, Chavda KD, Fraimow HS, Mediavilla JR, Melano RG, Jacobs MR, et al. Complete nucleotide sequences of blaKPC-4- And blaKPC-5-harboring IncN and IncX plasmids from Klebsiella pneumoniae strains isolated in New Jersey. Antimicrob Agents Chemother. 2013; 57(1): 269-276. doi: 10.1128/AAC.01648-12 PMID: 23114770
54. Partridge SR, Ellem JA, Tetu SG, Zong Z, Paulsen IT, Iredell JR. Complete sequence of pJIE143, a pirtype plasmid carrying ISEcp1-blaCTX-M-15 from an Escherichia coli ST131 isolate. Antimicrob Agents Chemother. 2011; 55(12): 5933-5935. doi: 10.1128/AAC.00639-11 PMID: 21911569
55. Feng J, Qiu Y, Yin Z, Chen W, Yang H, Yang W, et al. Coexistence of a novel KPC-2-encoding MDR plasmid and an NDM-1-encoding pNDM-HN380-like plasmid in a clinical isolate of Citrobacter freundii. J Antimicrob Chemother. 2015; 70(11): 2987-2991. doi: 10.1093/jac/dkv232 PMID: 26260129
56. Espedido BA, Thomas LC, Iredell JR. Metallo-ß-lactamase or extended-spectrum ßlactamase: A wolf in sheep's clothing. J Clin Microbiol. 2007; 45(6): 2034-2036. doi: 10.1128/JCM.02538-06 PMID: 17409217
57. Barton BM, Harding GP, Zuccarelli AJ. A general method for detecting and sizing large plasmids. Anal Biochem. 1995; 226(2): 235-240. doi: 10.1006/abio.1995.1220 PMID: 7793624
58. Seedorf H, Griffin NW, Ridaura VK, Reyes A, Cheng J, Rey FE, et al. Bacteria from diverse habitats colonize and compete in the mouse gut. Cell. 2014; 159(2): 253-266. doi: 10.1016/j.cell.2014.09.008 PMID: 25284151
59. Pimentel B, Nair R, Bermejo-Rodriguez C, Preston MA, Agu CA, Wang X, et al. Toxin Kid uncouples DNA replication and cell division to enforce retention of plasmid R1 in Escherichia coli cells. Proc Natl Acad Sci U S A. 2014; 111(7): 2734-2739. doi: 10.1073/pnas.1308241111 PMID: 24449860
60. Gardner MN, Rawlings DE. Evolution of compatible replicons of the related IncQ-like plasmids, pTCF14 and pTF-FC2. Microbiology. 2004; 150(Pt 6): 1797-1808. doi: 10.1099/mic.0.26951-0 PMID: 15184566
61. Raz R. Fosfomycin: An old-new antibiotic. Clin Microbiol Infect. 2012; 18(1): 4-7. doi: 10.1111/j.1469- 0691.2011.03636.x PMID: 21914036